Editorial: Surgical oncology trials and surgeons in the real world!

Annals of Surgical Oncology

Volumn 17, Issue 7, 2010, Pages 1727-1728

  Al Refaie, Waddah B ^a   Pisters, Peter W P T ^b   Rothenberger, David A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; SURGEON; CLINICAL TRIAL; GENERAL SURGERY; NEOPLASM; ONCOLOGY; PATIENT PARTICIPATION; PATIENT SELECTION;

CLINICAL TRIALS AS TOPIC; GENERAL SURGERY; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT PARTICIPATION; PATIENT SELECTION;

EID: 77954954520     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1069-1     Document Type: Editorial

References (16)

1. Brennan MF. Commentary: randomized controlled trials. Surg Oncol Clin N Am. 2010;19: xix-xx.
2. Meyer RM. Generalizing the results of cancer clinical trials. J Clin Oncol. 2010;28:187-9.
3. Brooks AD, Karpoff HM, Sulimanoff I, Coit D, Brennan MF, Jaques DP. The search for level I evidence in solid-tumor oncology. Ann Surg Oncol. 2001;8:638-43.
4. Elting LS, Cooksley C, Bekele BN, Frumovitz M, Avritscher EB, Sun C, et al. Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer. 2006;106:2452-8.
5. Rothenberger DA. Evidence-based practice requires evidence. Br J Surg. 2004;91:1387-8.
6. Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006;24:4545-52.
7. Swanson GM, Bailar JC, 3rd. Selection and description of cancer clinical trials participants-science or happenstance? Cancer. 2002;95:950-9.
8. Lund MJ, Eliason MT, Haight AE, Ward KC, Young JL, Pentz RD. Racial/ethnic diversity in children's oncology clinical trials: ten years later. Cancer. 2009;115:3808-16.
9. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328-34.
10. Gross CP, Filardo G, Mayne ST, Krumholz HM. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2005;103:483-91.
11. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061-7.
12. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720-6.
13. Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, et al. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg. 2004;199:644-51.
14. Al-Refaie WB, Habermann EB, Dudeja V, Vickers SM, Tuttle TM, Jensen EH, et al. Extremity soft tissue sarcoma care in the elderly: insights into the generalizability of NCI trials. Ann Surg Oncol. 2010 [Epub ahead of print].
15. Al-Refaie WB, Parsons HM, Henderson WG, Jensen EH, Tuttle TM, Vickers SM, et al. Major cancer surgery in the elderly: results from the American College of Surgeons National Surgical Quality Improvement Program. Ann Surg. 2010;251:311-8.
16. Lamont EB, Landrum MB, Keating NL, Archer L, Lan L, Strauss GM, et al. Differences in clinical trial patient attributes and outcomes according to enrollment setting. J Clin Oncol. 2010;28:215-21.